InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Aggarwal Gaurav, 董事. Director active across 4 companies, notably Sierra Oncology, Inc.. Cumulatively, 9 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €19.4m. History available since 26 January 2022. The latest transaction was filed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Gaurav Aggarwal is Administrateur. He has 9 filings in total, and in the recent filings available, the aggregated amounts show EUR 19368072 of buys and EUR 143611897 of sells, over a period from 2016-01-19 to 2025-08-26. He is linked to Unicycive Therapeutics, Inc., Sierra Oncology, Inc., GERON CORP and Ocera Therapeutics, Inc.